BACKGROUND. The use of autologous bone marrow transplantation is increasing in the management of advanced cancers. Many investigators have attempted to "purge" autologous marrow of residual tumor cells because of concern that reinfused tumor cells might contribute to relapse. The efficacy of purging remains unproved. METHODS. We performed clonogenic assays in a tumor cell line in culture to determine the efficiency of immunologic purging. Amplification by the polymerase chain reaction (PCR) was used to detect residual lymphoma cells before and after purging of bone marrow from 114 patients with B-cell non-Hodgkin's lymphoma in whom a translocation (t(14;18] that could be amplified by PCR was detected at the time of their initial evaluation. RESULTS. Immunologic purging in vitro resulted in a 3-to-6-log destruction of cells in the tumor cell line. Residual lymphoma cells were detected by PCR in the bone marrow of all patients before purging. No lymphoma cells could be detected in the marrow of 57 patients after purging. Disease-free survival was increased in these 57 patients as compared with those whose marrow contained detectable residual lymphoma (P less than 0.00001). The ability to purge residual lymphoma cells was not associated with the degree of bone marrow involvement (P = 0.4494) or the previous response to therapy (P = 0.1298). CONCLUSIONS. The inability to purge residual lymphoma cells was the most important prognostic indicator in predicting relapse. These results provide evidence of the clinical usefulness of ex vivo purging of autologous bone marrow in the treatment of patients with lymphoma and suggest that the reinfusion of malignant cells in autologous marrow contributes to relapse
Source Information
Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, MA 02115.
This article has been cited by other articles:
Kasamon, Y. L., Jones, R. J., Brodsky, R. A., Fuchs, E. J., Matsui, W., Luznik, L., Powell, J. D., Blackford, A. L., Goodrich, A., Gocke, C. D., Abrams, R. A., Ambinder, R. F., Flinn, I. W.
(2009). Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma. Ann Oncol
0: mdp484v1-mdp484
[Abstract][Full Text]
Gisselbrecht, C., Vose, J., Nademanee, A., Gianni, A. M., Nagler, A.
(2009). Radioimmunotherapy for Stem Cell Transplantation in Non-Hodgkin's Lymphoma: In Pursuit of a Complete Response. The Oncologist
14: 41-51
[Abstract][Full Text]
Kornacker, M., Stumm, J., Pott, C., Dietrich, S., Sussmilch, S., Hensel, M., Nickelsen, M., Witzens-Harig, M., Kneba, M., Schmitz, N., Ho, A. D., Dreger, P.
(2009). Characteristics of relapse after autologous stem-cell transplantation for follicular lymphoma: a long-term follow-up. Ann Oncol
20: 722-728
[Abstract][Full Text]
Gyan, E., Foussard, C., Bertrand, P., Michenet, P., Le Gouill, S., Berthou, C., Maisonneuve, H., Delwail, V., Gressin, R., Quittet, P., Vilque, J.-P., Desablens, B., Jaubert, J., Ramee, J.-F., Arakelyan, N., Thyss, A., Molucon-Chabrot, C., Delepine, R., Milpied, N., Colombat, P., Deconinck, E., for the Groupe Ouest-Est des Leucemies et des Autr,
(2009). High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years. Blood
113: 995-1001
[Abstract][Full Text]
Ladetto, M., De Marco, F., Benedetti, F., Vitolo, U., Patti, C., Rambaldi, A., Pulsoni, A., Musso, M., Liberati, A. M., Olivieri, A., Gallamini, A., Pogliani, E., Scalabrini, D. R., Callea, V., Di Raimondo, F., Pavone, V., Tucci, A., Cortelazzo, S., Levis, A., Boccadoro, M., Majolino, I., Pileri, A., Gianni, A. M., Passera, R., Corradini, P., Tarella, C., for Gruppo Italiano Trapianto di Midollo Osseo (GI,
(2008). Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage. Blood
111: 4004-4013
[Abstract][Full Text]
Gribben, J. G.
(2007). How I treat indolent lymphoma. Blood
109: 4617-4626
[Abstract][Full Text]
Press, O. W., Unger, J. M., Braziel, R. M., Maloney, D. G., Miller, T. P., LeBlanc, M., Fisher, R. I.
(2006). Phase II Trial of CHOP Chemotherapy Followed by Tositumomab/Iodine I-131 Tositumomab for Previously Untreated Follicular Non-Hodgkin's Lymphoma: Five-Year Follow-Up of Southwest Oncology Group Protocol S9911. JCO
24: 4143-4149
[Abstract][Full Text]
Janni, W., Rack, B., Lindemann, K., Harbeck, N.
(2005). Detection of Micrometastatic Disease in Bone Marrow: Is It Ready for Prime Time?. The Oncologist
10: 480-492
[Abstract][Full Text]
Deconinck, E., Foussard, C., Milpied, N., Bertrand, P., Michenet, P., Cornillet-LeFebvre, P., Escoffre-Barbe, M., Maisonneuve, H., Delwail, V., Gressin, R., Legouffe, E., Vilque, J.-P., Desablens, B., Jaubert, J., Ramee, J.-F., Jenabian, A., Thyss, A., Le Pourhiet-Le Mevel, A., Travade, P., Delepine, R., Colombat, P., GOELAMS,
(2005). High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS. Blood
105: 3817-3823
[Abstract][Full Text]
Rambaldi, A., Carlotti, E., Oldani, E., Starza, I. D., Baccarani, M., Cortelazzo, S., Lauria, F., Arcaini, L., Morra, E., Pulsoni, A., Rigacci, L., Rupolo, M., Zaja, F., Zinzani, P. L., Barbui, T., Foa, R.
(2005). Quantitative PCR of bone marrow BCL2/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphoma. Blood
105: 3428-3433
[Abstract][Full Text]
Lenz, G., Dreyling, M., Schiegnitz, E., Forstpointner, R., Wandt, H., Freund, M., Hess, G., Truemper, L., Diehl, V., Kropff, M., Kneba, M., Schmitz, N., Metzner, B., Pfirrmann, M., Unterhalt, M., Hiddemann, W.
(2004). Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group. Blood
104: 2667-2674
[Abstract][Full Text]
Carlo-Stella, C., Di Nicola, M., Milani, R., Guidetti, A., Magni, M., Milanesi, M., Longoni, P., Matteucci, P., Formelli, F., Ravagnani, F., Corradini, P., Gianni, A. M.
(2004). Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizers. Blood
103: 3287-3295
[Abstract][Full Text]
Corradini, P., Ladetto, M., Zallio, F., Astolfi, M., Rizzo, E., Sametti, S., Cuttica, A., Rosato, R., Farina, L., Boccadoro, M., Benedetti, F., Pileri, A., Tarella, C.
(2004). Long-Term Follow-Up of Indolent Lymphoma Patients Treated With High-Dose Sequential Chemotherapy and Autografting: Evidence That Durable Molecular and Clinical Remission Frequently Can Be Attained Only in Follicular Subtypes. JCO
22: 1460-1468
[Abstract][Full Text]
Horwitz, S. M., Negrin, R. S., Blume, K. G., Breslin, S., Stuart, M. J., Stockerl-Goldstein, K. E., Johnston, L. J., Wong, R. M., Shizuru, J. A., Horning, S. J.
(2004). Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma. Blood
103: 777-783
[Abstract][Full Text]
van Besien, K., Loberiza, F. R. Jr, Bajorunaite, R., Armitage, J. O., Bashey, A., Burns, L. J., Freytes, C. O., Gibson, J., Horowitz, M. M., Inwards, D. J., Marks, D. I., Martino, R., Maziarz, R. T., Molina, A., Pavlovsky, S., Pecora, A. L., Schouten, H. C., Shea, T. C., Lazarus, H. M., Rizzo, J. D., Vose, J. M.
(2003). Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma. Blood
102: 3521-3529
[Abstract][Full Text]
Borchmann, P., Treml, J. F., Hansen, H., Gottstein, C., Schnell, R., Staak, O., Zhang, H.-f., Davis, T., Keler, T., Diehl, V., Graziano, R. F., Engert, A.
(2003). The human anti-CD30 antibody 5F11 shows in vitro and in vivo activity against malignant lymphoma. Blood
102: 3737-3742
[Abstract][Full Text]
Schouten, H. C., Qian, W., Kvaloy, S., Porcellini, A., Hagberg, H., Johnsen, H. E., Doorduijn, J. K., Sydes, M. R., Kvalheim, G.
(2003). High-Dose Therapy Improves Progression-Free Survival and Survival in Relapsed Follicular Non-Hodgkin's Lymphoma: Results From the Randomized European CUP Trial. JCO
21: 3918-3927
[Abstract][Full Text]
Bishop, M. R.
(2003). The Graft-Versus-Lymphoma Effect: Fact, Fiction, or Opportunity?. JCO
21: 3713-3715
[Full Text]
Bierman, P. J., Sweetenham, J. W., Loberiza, F. R. Jr, Taghipour, G., Lazarus, H. M., Rizzo, J. D., Schmitz, N., van Besien, K., Vose, J. M., Horowitz, M., Goldstone, A.
(2003). Syngeneic Hematopoietic Stem-Cell Transplantation for Non-Hodgkin's Lymphoma: A Comparison With Allogeneic and Autologous Transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. JCO
21: 3744-3753
[Abstract][Full Text]
Press, O. W., Unger, J. M., Braziel, R. M., Maloney, D. G., Miller, T. P., LeBlanc, M., Gaynor, E. R., Rivkin, S. E., Fisher, R. I.
(2003). A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911. Blood
102: 1606-1612
[Abstract][Full Text]
Chen, T.-Y., Chen, H. H. W., Su, W.-C., Tsao, C.-J.
(2003). High-dose Chemotherapy and Hematopoietic Stem Cell Transplantation for Patients with Nasopharyngeal Cancer: a Feasibility Study. Jpn J Clin Oncol
33: 331-335
[Abstract][Full Text]
Fernandez-Ruiz, E., Cabrerizo, M., Ortega, M., Blas, C., Llamas, P., Santos-Roncero, M., Nieto, S., Acevedo, A., Perez, G., Nicolas, C., Fernandez-Ranada, J. M., Arranz, R.
(2003). High Molecular Response Rate and Clinical Correlation in Patients with Follicular Lymphoma Treated with Cyclophosphamide-Vincristine-Prednisone plus Interferon {alpha} 2b. Clin. Cancer Res.
9: 2497-2503
[Abstract][Full Text]
Thirukkumaran, C. M., Luider, J. M., Stewart, D. A., Cheng, T., Lupichuk, S. M., Nodwell, M. J., Russell, J. A., Auer, I. A., Morris, D. G.
(2003). Reovirus oncolysis as a novel purging strategy for autologous stem cell transplantation. Blood
102: 377-387
[Abstract][Full Text]
Schnell, R., Borchmann, P., Staak, J. O., Schindler, J., Ghetie, V., Vitetta, E. S., Engert, A.
(2003). Clinical evaluation of ricin A-chain immunotoxins in patients with Hodgkin's lymphoma. Ann Oncol
14: 729-736
[Abstract][Full Text]
Ladetto, M., Drandi, D., Compagno, M., Astolfi, M., Volpato, F., Voena, C., Novarino, A., Pollio, B., Addeo, A., Ricca, I., Falco, P., Cavallo, F., Vallet, S., Corradini, P., Pileri, A., Tamponi, G., Palumbo, A., Bertetto, O., Boccadoro, M., Tarella, C.
(2003). PCR-Detectable Nonneoplastic Bcl-2/IgH Rearrangements Are Common in Normal Subjects and Cancer Patients at Diagnosis but Rare in Subjects Treated With Chemotherapy. JCO
21: 1398-1403
[Abstract][Full Text]
Malphettes, M., Carcelain, G., Saint-Mezard, P., Leblond, V., Altes, H. K., Marolleau, J.-P., Debre, P., Brouet, J.-C., Fermand, J.-P., Autran, B.
(2003). Evidence for naive T-cell repopulation despite thymus irradiation after autologous transplantation in adults with multiple myeloma: role of ex vivo CD34+ selection and age. Blood
101: 1891-1897
[Abstract][Full Text]
Borchmann, P., Schnell, R., Fuss, I., Manzke, O., Davis, T., Lewis, L. D., Behnke, D., Wickenhauser, C., Schiller, P., Diehl, V., Engert, A.
(2002). Phase 1 trial of the novel bispecific molecule H22xKi-4 in patients with refractory Hodgkin lymphoma. Blood
100: 3101-3107
[Abstract][Full Text]
Branson, K., Chopra, R., Kottaridis, P. D., McQuaker, G., Parker, A., Schey, S., Chakraverty, R. K., Craddock, C., Milligan, D. W., Pettengell, R., Marsh, J. C.W., Linch, D. C., Goldstone, A. H., Williams, C. D., Mackinnon, S.
(2002). Role of Nonmyeloablative Allogeneic Stem-Cell Transplantation After Failure of Autologous Transplantation in Patients With Lymphoproliferative Malignancies. JCO
20: 4022-4031
[Abstract][Full Text]
Wagner, L. M., Guichard, S. M., Burger, R. A., Morton, C. L., Straign, C. M., Ashmun, R. A., Harris, L. C., Houghton, P. J., Potter, P. M., Danks, M. K.
(2002). Efficacy and Toxicity of a Virus-directed Enzyme Prodrug Therapy Purging Method: Preclinical Assessment and Application to Bone Marrow Samples from Neuroblastoma Patients. Cancer Res.
62: 5001-5007
[Abstract][Full Text]
Ladetto, M., Corradini, P., Vallet, S., Benedetti, F., Vitolo, U., Martelli, M., Brugiatelli, M., Coser, P., Perrotti, A., Majolino, I., Fioritoni, G., Morandi, S., Musso, M., Zambello, R., Chisesi, T., Di Renzo, N., Vivaldi, P., De Crescenzo, A., Gallamini, A., Salvi, F., Santini, G., Boccomini, C., Sorio, M., Astolfi, M., Drandi, D., Pileri, A., Tarella, C.
(2002). High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO). Blood
100: 1559-1565
[Abstract][Full Text]
Hunault-Berger, M., Ifrah, N., Solal-Celigny, P.
(2002). Intensive therapies in follicular non-Hodgkin lymphomas. Blood
100: 1141-1152
[Full Text]
Schnell, R., Staak, O., Borchmann, P., Schwartz, C., Matthey, B., Hansen, H., Schindler, J., Ghetie, V., Vitetta, E. S., Diehl, V., Engert, A.
(2002). A Phase I Study with an Anti-CD30 Ricin A-Chain Immunotoxin (Ki-4.dgA) in Patients with Refractory CD30+ Hodgkin's and Non-Hodgkin's Lymphoma. Clin. Cancer Res.
8: 1779-1786
[Abstract][Full Text]
Vose, J. M., Sharp, G., Chan, W. C., Nichols, C., Loh, K., Inwards, D., Rifkin, R., Bierman, P. J., Lynch, J. C., Weisenburger, D. D., Kessinger, A., Armitage, J. O.
(2002). Autologous Transplantation for Aggressive Non-Hodgkin's Lymphoma: Results of a Randomized Trial Evaluating Graft Source and Minimal Residual Disease. JCO
20: 2344-2352
[Abstract][Full Text]
Rambaldi, A., Lazzari, M., Manzoni, C., Carlotti, E., Arcaini, L., Baccarani, M., Barbui, T., Bernasconi, C., Dastoli, G., Fuga, G., Gamba, E., Gargantini, L., Gattei, V., Lauria, F., Lazzarino, M., Mandelli, F., Morra, E., Pulsoni, A., Ribersani, M., Rossi-Ferrini, P. L., Rupolo, M., Tura, S., Zagonel, V., Zaja, F., Zinzani, P., Reato, G., Foa, R.
(2002). Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma. Blood
99: 856-862
[Abstract][Full Text]
Merino, M. E., Navid, F., Christensen, B. L., Toretsky, J. A., Helman, L. J., Cheung, N.-K. V., Mackall, C. L.
(2001). Immunomagnetic Purging of Ewing's Sarcoma From Blood and Bone Marrow: Quantitation by Real-Time Polymerase Chain Reaction. JCO
19: 3649-3659
[Abstract][Full Text]
Mink, S. A., Armitage, J. O.
(2001). High-Dose Therapy in Lymphomas: A Review of the Current Status of Allogeneic and Autologous Stem Cell Transplantation in Hodgkin's Disease and Non-Hodgkin's Lymphoma. The Oncologist
6: 247-256
[Abstract][Full Text]
Horning, S. J., Negrin, R. S., Hoppe, R. T., Rosenberg, S. A., Chao, N. J., Long, G. D., Brown, B. W., Blume, K. G.
(2001). High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial. Blood
97: 404-409
[Abstract][Full Text]
Mohr, M., Dalmis, F., Hilgenfeld, E., Oelmann, E., Zühlsdorf, M., Kratz-Albers, K., Nolte, A., Schmitmann, C., Önaldi-Mohr, D., Cassens, U., Serve, H., Sibrowski, W., Kienast, J., Berdel, W. E.
(2001). Simultaneous Immunomagnetic CD34+ Cell Selection and B-Cell Depletion in Peripheral Blood Progenitor Cell Samples of Patients Suffering from B-Cell Non-Hodgkin's Lymphoma. Clin. Cancer Res.
7: 51-57
[Abstract][Full Text]
Zippelius, A., Lutterbüse, R., Riethmüller, G., Pantel, K.
(2000). Analytical Variables of Reverse Transcription-Polymerase Chain Reaction-based Detection of Disseminated Prostate Cancer Cells. Clin. Cancer Res.
6: 2741-2750
[Abstract][Full Text]
Willems, P., Verhagen, O., Segeren, C., Veenhuizen, P., Guikema, J., Wiemer, E., Groothuis, L., Jong, T. B.-d., Kok, H., Bloem, A., Bos, N., Vellenga, E., Mensink, E., Sonneveld, P., Lokhorst, H., van der Schoot, E., Raymakers, R.
(2000). Consensus strategy to quantitate malignant cells in myeloma patients is validated in a multicenter study. Blood
96: 63-70
[Abstract][Full Text]
Barth, S., Huhn, M., Matthey, B., Tawadros, S., Schnell, R., Schinkothe, T., Diehl, V., Engert, A.
(2000). Ki-4(scFv)-ETA', a new recombinant anti-CD30 immunotoxin with highly specific cytotoxic activity against disseminated Hodgkin tumors in SCID mice. Blood
95: 3909-3914
[Abstract][Full Text]
Schröder, C. P., Kroesen, B.-J., de Leij, L. F. M. H., de Vries, E. G. E.
(2000). Purging of Epithelial Tumor Cells from Peripheral Blood Stem Cells by Means of the Bispecific Antibody BIS-1. Clin. Cancer Res.
6: 2521-2527
[Abstract][Full Text]
Lemoli, R. M., Martinelli, G., Zamagni, E., Motta, M. R., Rizzi, S., Terragna, C., Rondelli, R., Ronconi, S., Curti, A., Bonifazi, F., Tura, S., Cavo, M.
(2000). Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapy. Blood
95: 2234-2239
[Abstract][Full Text]
Apostolidis, J., Gupta, R. K., Grenzelias, D., Johnson, P. W. M., Pappa, V. I., Summers, K. E., Salam, A., Adams, K., Norton, A. J., Amess, J. A. L., Matthews, J., Bradburn, M., Lister, T. A., Rohatiner, A. Z. S.
(2000). High-Dose Therapy With Autologous Bone Marrow Support as Consolidation of Remission in Follicular Lymphoma: Long-Term Clinical and Molecular Follow-Up. JCO
18: 527-527
[Abstract][Full Text]
Cabanillas, F., Horning, S., Kaminski, M., Champlin, R.
(2000). Managing Indolent Lymphomas in Relapse: Working Our Way Through a Plethora of Options. ASH Education Book
2000: 166-179
[Abstract][Full Text]
Elias, A.
(1999). Hematopoietic Stem Cell Transplantation for Small Cell Lung Cancer*. Chest
116
: 531S-538S
[Abstract][Full Text]
Freedman, A. S., Neuberg, D., Mauch, P., Soiffer, R. J., Anderson, K. C., Fisher, D. C., Schlossman, R., Alyea, E. P., Takvorian, T., Jallow, H., Kuhlman, C., Ritz, J., Nadler, L. M., Gribben, J. G.
(1999). Long-Term Follow-Up of Autologous Bone Marrow Transplantation in Patients With Relapsed Follicular Lymphoma. Blood
94: 3325-3333
[Abstract][Full Text]
LaCasse, E.C., Bray, M.R., Patterson, B., Lim, W.-M., Perampalam, S., Radvanyi, L. G., Keating, A., Stewart, A.K., Buckstein, R., Sandhu, J.S., Miller, N., Banerjee, D., Singh, D., Belch, A.R., Pilarski, L.M., Gariepy, J.
(1999). Shiga-Like Toxin-1 Receptor on Human Breast Cancer, Lymphoma, and Myeloma and Absence From CD34+ Hematopoietic Stem Cells: Implications for Ex Vivo Tumor Purging and Autologous Stem Cell Transplantation. Blood
94: 2901-2910
[Abstract][Full Text]
Grossbard, M. L., Multani, P. S., Freedman, A. S., O'Day, S., Gribben, J. G., Rhuda, C., Neuberg, D., Nadler, L. M.
(1999). A Phase II Study of Adjuvant Therapy with Anti-B4-blocked Ricin after Autologous Bone Marrow Transplantation for Patients with Relapsed B-Cell Non-Hodgkin's Lymphoma. Clin. Cancer Res.
5: 2392-2398
[Abstract][Full Text]
Pantel, K., Cote, R. J., Fodstad, O.
(1999). Detection and Clinical Importance of Micrometastatic Disease. JNCI J Natl Cancer Inst
91: 1113-1124
[Abstract][Full Text]
Franklin, W. A., Glaspy, J., Pflaumer, S. M., Jones, R. B., Hami, L., Martinez, C., Murphy, J. R., Shpall, E. J.
(1999). Incidence of Tumor-Cell Contamination in Leukapheresis Products of Breast Cancer Patients Mobilized With Stem Cell Factor and Granulocyte Colony-Stimulating Factor (G-CSF) or With G-CSF Alone. Blood
94: 340-347
[Abstract][Full Text]
Marini, F. C., Snell, V., Yu, Q., Zhang, X., Singletary, S. E., Champlin, R., Andreeff, M.
(1999). Purging of Contaminating Breast Cancer Cells from Hematopoietic Stem Cell Grafts by Adenoviral GAL-TEK Gene Therapy and Magnetic Antibody Cell Separation. Clin. Cancer Res.
5: 1557-1568
[Abstract][Full Text]
Mohr, M., Hilgenfeld, E., Fietz, T., Hoppe, B., Koenigsmann, M., Hoffmann, M., Knauf, W. U., Cassens, U., Sibrowski, W., Kienast, J., Thiel, E., Berdel, W. E.
(1999). Efficacy and Safety of Simultaneous Immunomagnetic CD34+ Cell Selection and Breast Cancer Cell Purging in Peripheral Blood Progenitor Cell Samples Used for Hematopoietic Rescue after High-Dose Therapy. Clin. Cancer Res.
5: 1035-1040
[Abstract][Full Text]
Elias, A., Ibrahim, J., Skarin, A. T., Wheeler, C., McCauley, M., Ayash, L., Richardson, P., Schnipper, L., Antman, K. H., Frei, E. III
(1999). Dose-Intensive Therapy for Limited-Stage Small-Cell Lung Cancer: Long-Term Outcome. JCO
17: 1175-1175
[Abstract][Full Text]
Vescio, R., Schiller, G., Stewart, A. K., Ballester, O., Noga, S., Rugo, H., Freytes, C., Stadtmauer, E., Tarantolo, S., Sahebi, F., Stiff, P., Meharchard, J., Schlossman, R., Brown, R., Tully, H., Benyunes, M., Jacobs, C., Berenson, R., DiPersio, J., Anderson, K., Berenson, J.
(1999). Multicenter Phase III Trial to Evaluate CD34+ Selected Versus Unselected Autologous Peripheral Blood Progenitor Cell Transplantation in Multiple Myeloma. Blood
93: 1858-1868
[Abstract][Full Text]
Apostolidis, J., Foran, J. M., Johnson, P.W.M., Norton, A., Amess, J., Matthews, J., Bradburn, M., Lister, T.A., Rohatiner, A. Z.S.
(1999). Patterns of Outcome Following Recurrence After Myeloablative Therapy With Autologous Bone Marrow Transplantation for Follicular Lymphoma. JCO
17: 216-216
[Abstract][Full Text]
Shipp, M.A., Abeloff, M.D., Antman, K.H., Carroll, G., Hagenbeek, A., Loeffler, M., Montserrat, E., Radford, J.A., Salles, G., Schmitz, N., Symann, M., Armitage, J.O., Philip, T., Coiffier, B.
(1999). International Consensus Conference on High-Dose Therapy With Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: Report of the Jury. JCO
17: 423-423
[Full Text]
van Besien, K., Sobocinski, K. A., Rowlings, P. A., Murphy, S. C., Armitage, J. O., Bishop, M. R., Chaekal, O.-k., Gale, R. P., Klein, J. P., Lazarus, H. M., McCarthy, P. L. Jr, Raemaekers, J. M.M., Reiffers, J., Phillips, G. L., Schattenberg, A. V.M.B., Verdonck, L. F., Vose, J. M., Horowitz, M. M.
(1998). Allogeneic Bone Marrow Transplantation for Low-Grade Lymphoma. Blood
92: 1832-1836
[Abstract][Full Text]
Gravel, S., Delsol, G., Al Saati, T.
(1998). Single-Cell Analysis of the t(14;18)(q32;q21) Chromosomal Translocation in Hodgkin's Disease Demonstrates the Absence of This Translocation in Neoplastic Hodgkin and Reed-Sternberg Cells. Blood
91: 2866-2874
[Abstract][Full Text]
Lopez-Guillermo, A., Cabanillas, F., McLaughlin, P., Smith, T., Hagemeister, F., Rodriguez, M. A., Romaguera, J. E., Younes, A., Sarris, A. H., Preti, H. A., Pugh, W., Lee, M.-S.
(1998). The Clinical Significance of Molecular Response in Indolent Follicular Lymphomas. Blood
91: 2955-2960
[Abstract][Full Text]
Rambaldi, A., Borleri, G., Dotti, G., Bellavita, P., Amaru, R., Biondi, A., Barbui, T.
(1998). Innovative Two-Step Negative Selection of Granulocyte Colony-Stimulating Factor-Mobilized Circulating Progenitor Cells: Adequacy for Autologous and Allogeneic Transplantation. Blood
91: 2189-2196
[Abstract][Full Text]
Ghia, P., Boussiotis, V. A., Schultze, J. L., Cardoso, A. A., Dorfman, D. M., Gribben, J. G., Freedman, A. S., Nadler, L. M.
(1998). Unbalanced Expression of Bcl-2 Family Proteins in Follicular Lymphoma: Contribution of CD40 Signaling in Promoting Survival. Blood
91: 244-251
[Abstract][Full Text]
Leonard, B. M., Hetu, F., Busque, L., Gyger, M., Belanger, R., Perreault, C., Roy, D.-C.
(1998). Lymphoma Cell Burden in Progenitor Cell Grafts Measured by Competitive Polymerase Chain Reaction: Less Than One Log Difference Between Bone Marrow and Peripheral Blood Sources. Blood
91: 331-339
[Abstract][Full Text]
Andersen, N. S., Donovan, J. W., Borus, J. S., Poor, C. M., Neuberg, D., Aster, J. C., Nadler, L. M., Freedman, A. S., Gribben, J. G.
(1997). Failure of Immunologic Purging in Mantle Cell Lymphoma Assessed by Polymerase Chain Reaction Detection of Minimal Residual Disease. Blood
90: 4212-4221
[Abstract][Full Text]
Jennings, C. D., Foon, K. A.
(1997). Recent Advances in Flow Cytometry: Application to the Diagnosis of Hematologic Malignancy. Blood
90: 2863-2892
[Full Text]
Lopez, M., Lemoine, F.M., Firat, H., Fouillard, L., Laporte, J.P., Lesage, S., Isnard, F., Stachowiak, J., Ferrer-Le Coeur, F., Morel, P., Najman, A., Douay, L., Gorin, N.C.
(1997). Bone Marrow Versus Peripheral Blood Progenitor Cells CD34 Selection in Patients With Non-Hodgkin's Lymphomas: Different Levels of Tumor Cell Reduction. Implications for Autografting. Blood
90: 2830-2838
[Abstract][Full Text]
Lowdell, M. W., Theocharous, P.
(1997). "Less is More": The Role of Purging in Hematopoietic Stem Cell Transplantation. The Oncologist
2: 268-274
[Full Text]
Schultze, J. L., Seamon, M. J., Michalak, S., Gribben, J. G., Nadler, L. M.
(1997). Autologous Tumor Infiltrating T Cells Cytotoxic for Follicular Lymphoma Cells Can Be Expanded In Vitro. Blood
89: 3806-3816
[Abstract][Full Text]
Lie, A. K.W., To, L. B.
(1997). Peripheral Blood Stem Cells: Transplantation and Beyond. The Oncologist
2: 40-49
[Abstract][Full Text]
Engert, A., Diehl, V., Schnell, R., Radszuhn, A., Hatwig, M.-T., Drillich, S., Schon, G., Bohlen, H., Tesch, H., Hansmann, M.-L., Barth, S., Schindler, J., Ghetie, V., Uhr, J., Vitetta, E.
(1997). A Phase-I Study of an Anti-CD25 Ricin A-Chain Immunotoxin (RFT5-SMPT-dgA) in Patients With Refractory Hodgkin's Lymphoma. Blood
89: 403-410
[Abstract][Full Text]
Corradini, P., Astolfi, M., Cherasco, C., Ladetto, M., Voena, C., Caracciolo, D., Pileri, A., Tarella, C.
(1997). Molecular Monitoring of Minimal Residual Disease in Follicular and Mantle Cell Non-Hodgkin's Lymphomas Treated With High-Dose Chemotherapy and Peripheral Blood Progenitor Cell Autografting. Blood
89: 724-491
[Abstract][Full Text]
Woo, S.-B., Lee, S. J., Schubert, M. M.
(1997). Graft-vs.-Host Disease. CROBM
8: 201-216
[Abstract][Full Text]
Armitage, J. O.
(1994). Bone Marrow Transplantation. NEJM
330: 827-838
[Full Text]
Brenner, M.K., Heslop, H.E., Rill, D., Li, C., Nilson, T., Roberts, M., Smith, C., Krance, R., Rooney, C.
(1994). Gene Transfer and Bone Marrow Transplantation. Cold Spring Harb Symp Quant Biol
59: 691-697
[Abstract]
Bast, R. C.
(1993). Progress in Radioimmunotherapy. NEJM
329: 1266-1268
[Full Text]
Armitage, J. O.
(1993). Treatment of Non-Hodgkin's Lymphoma. NEJM
328: 1023-1030
[Full Text]
